Hcp Life Science
HCP Life Science, headquartered in the United States, is a prominent player in the life sciences industry, specialising in innovative solutions for biopharmaceutical and biotechnology sectors. Founded in 2010, the company has established itself as a leader in providing high-quality laboratory services and products, including analytical testing, bioprocessing, and regulatory support. With a strong presence across North America and Europe, HCP Life Science is recognised for its commitment to excellence and customer-centric approach. The company’s unique offerings, such as customised testing protocols and state-of-the-art technology, set it apart in a competitive market. HCP Life Science has achieved significant milestones, including partnerships with leading pharmaceutical companies, solidifying its position as a trusted provider in the life sciences landscape.
DitchCarbon Score
How does Hcp Life Science's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hcp Life Science's score of 28 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hcp Life Science's reported carbon emissions
Hcp Life Science's carbon emissions data reveals a significant reduction trend over recent years. In 2014, the company reported total emissions of approximately 398,118,000 kg CO2e, with Scope 1 emissions at about 49,369,000 kg CO2e and Scope 2 emissions at approximately 348,749,000 kg CO2e. By 2018, total emissions had decreased to around 299,392,000 kg CO2e, with Scope 1 emissions at about 54,260,000 kg CO2e, Scope 2 emissions at approximately 245,132,000 kg CO2e, and Scope 3 emissions contributing an additional 18,000,000 kg CO2e from various activities, including business travel and waste generated in operations. Despite these reductions, Hcp Life Science has not publicly disclosed specific reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to focus on improving its emissions intensity, as indicated by its ongoing efforts to enhance operational efficiency and sustainability practices. Overall, Hcp Life Science demonstrates a commitment to reducing its carbon footprint, aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Scope 1 | 49,369,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 348,749,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hcp Life Science is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
